Fellows of the British Pharmacological Society are members who have demonstrated distinction and peer recognition in pharmacology.
Fellows have made, and may continue to make, substantial contributions to the disciplines of pharmacology, clinical pharmacology and therapeutics, through their work, publication and presentation of research, leadership, and contribution to Society life.
Find out more and apply for Fellowship.
This directory has been created to increase the visibility of our Fellows and their contributions, and to support networking by providing a useful resource for members to connect with Fellows with similar areas of interest.
Here you can find profiles of each Fellow, including information on their institutional affiliation, year elected, primary professional setting, affinity group membership, and a short biography.
Select the magnifying glass icon to begin any searches.
Ulf Simonsen was educated as a medical doctor at Aarhus University, Denmark, in 1991 and has specialist courses in Clinical Pharmacology.
Dave Singh is professor of clinical pharmacology & respiratory medicine at the University of Manchester.
Dr Singh is currently working as a faculty at the Government Medical College and Hospital in Chandigarh, India.
Dr Skett is a Forensic Pharmacologist and Honorary Senior Lecturer in Pharmacology in the College of Medicine, Veterinary Medicine and Life Sciences at the University of Glasgow specialising specifically in the clearance of drugs from the body and the adverse effects of drugs.
I am an Executive Director and co-founder of DevelRx Ltd, which offers consultancy services to the pharmaceutical, biotech and food supplement industry.
Mark completed his PhD (2017) at the University of Nottingham under the supervision of Prof Stephen Hill and Prof Jeanette Woolard where studied the molecular pharmacology of an antibody raised against the Beta-1 adrenoceptor.
Chris Sobey obtained his PhD in 1991 from the University of Melbourne in Australia.
Professor Reecha Sofat is the inaugural Breckenridge Chair of Clinical Pharmacology and Therapeutics at the University of Liverpool, where she is also Head of Department of Pharmacology and Therapeutics.
Dr Egle Solito is Reader in Immunobiology and heads the Blood-Brain Barrier research group at William Harvey Research Institute Bart’s and the London Scholl of Medicine Queen Mary University London (WHRI-SMD).
Andrew Somogyi graduated in Pharmacy from Tasmania and at the University of Sydney completed a PhD in 1978.